Adam H. Schechter, President and CEO of Labcorp Holdings Inc. (NYSE:LH), a $20.4 billion healthcare services provider currently trading near its 52-week high of $258.59, sold 6,121 shares of the ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

“This transaction with Labcorp represents another important step for Opko Health to further streamline BioReference Health’s operations to achieve profitability,” Opko Chairman and CEO ...

Burlington, North Carolina-based Labcorp Holdings Inc. (LH) is a provider of laboratory services. It offers various tests, such as blood chemistry analyses, urinalyses, thyroid, PAP, substance ...

"In 2024, Labcorp delivered exceptional results driven by both organic and inorganic growth," said Adam Schechter, chairman and CEO of Labcorp. Labcorp Total Revenue Labcorp pulled off the highest ...